| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Zmira Lavie is Director at VICR. Zmira Lavie's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Zmira Lavie has 8 Form 4 filings on record from June 2022 to August 2026, all as Director at Vicor (VICR), 2022–2026.
The 15 reported transactions were 5 option exercises, 5 open-market sales and 5 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $833K.
The largest open-market sale was 3,720 shares of VICR at an average $89.58 on October 28, 2025, about $333K. Twelve months later VICR was up 142%.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.